Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 181

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Racial differences in neuromyelitis optica spectrum disorder

Open access
Kim, Su-Hyun, Mealy, Maureen A., Levy, Michael, Schmidt, Felix, Ruprecht, Klemens, Paul, Friedemann, Ringelstein, Marius, Aktas, Orhan, Hartung, Hans-Peter, Asgari, Nasrin, Tsz-Ching, Jessica Li, Siritho, Sasitorn, Prayoonwiwat, Naraporn, Shin, Hyun-June, Hyun, Jae-Won, Han, Mira, Leite, Maria Isabel, Palace, Jacqueline, Kim, Ho Jin · 2018 · Neurology

Abstract

Objective We aimed to evaluate racial differences in the clinical features of neuromyelitis optica spectrum disorder. Methods This retrospective review included 603 patients (304 Asian, 207 Caucasian, and 92 Afro-American/Afro-European), who were seropositive for anti–aquaporin-4 antibody, from 6 centers in Denmark, Germany, South Korea, United Kingdom, United States, and Thailand. Results Median disease duration at last follow-up was 8 years (range 0.3–38.4 years). Asian and Afro-American/Afro-European patients had a younger onset age than Caucasian patients (mean 36, 33, and 44 years, respectively; p < 0.001). During the disease course, Caucasian patients (23%) had a lower incidence of brain/brainstem involvement than Asian (42%) and Afro-American/Afro-European patients (38%) (p < 0.001). Severe attacks (visual acuity ≤0.1 in at least one eye or Expanded Disability Status Scale score ≥6.0 at nadir) at onset occurred more frequently in Afro-American/Afro-European (58%) than in Asian (46%) and Caucasian (38%) patients (p = 0.005). In the multivariable analysis, older age at onset, higher number of attacks before and after immunosuppressive treatment, but not race, were independent predictors of severe motor disabilities at last follow-up. Conclusion A review of a large international cohort revealed that race affected the clinical phenotype, age at onset, and severity of attacks, but the overall outcome was most dependent on early and effective immunosuppressive treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000006574

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 181

Metadata

Authors
Kim, S.-H., Mealy, M. A., Levy, M., Schmidt, F., Ruprecht, K., Paul, F., Ringelstein, M., Aktas, O., Hartung, H.-P., Asgari, N., Tsz-Ching, J. L., Siritho, S., Prayoonwiwat, N., Shin, H.-J., Hyun, J.-W., Han, M., Leite, M. I., Palace, J., & Kim, H. J.
Venue
Neurology
Published
2018-11-27
Volume
91
Issue
22
Pages
e2089-e2099
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2898365847
Cited by
181
References
4
FWCI
14.30
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Racial differences in neuromyelitis optica spectrum disorder. https://app.cochat.ai/papers/10.1212/wnl.0000000000006574
The paper
Kim, S.-H., Mealy, M. A., Levy, M., Schmidt, F., Ruprecht, K., Paul, F., Ringelstein, M., Aktas, O., Hartung, H.-P., Asgari, N., Tsz-Ching, J. L., Siritho, S., Prayoonwiwat, N., Shin, H.-J., Hyun, J.-W., Han, M., Leite, M. I., Palace, J., & Kim, H. J. (2018). Racial differences in neuromyelitis optica spectrum disorder. Neurology. https://doi.org/10.1212/wnl.0000000000006574

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.